Ovarian stimulation is the foundation of nearly every IVF cycle. It is the phase during which carefully dosed medications coax your ovaries into producing multiple mature eggs instead of the single egg your body would typically release each month. Understanding how this process works, what the medications do, and what your monitoring results mean can help demystify one of the most intensive phases of treatment. This article explains the science and practical experience of ovarian stimulation in detail.
Why Ovarian Stimulation Is Necessary
In a natural menstrual cycle, a group of small follicles begins growing at the start of each cycle, but your body's hormones quickly select one "dominant" follicle while the rest stop developing and are reabsorbed. This ensures that only one egg is released at ovulation, which is efficient from a biological standpoint but limiting for IVF.
The goal of IVF is to retrieve multiple mature eggs to maximize the chances of producing viable embryos. More eggs mean more opportunities for fertilization, more embryos to select from or test, and potentially more frozen embryos for future transfer cycles. Ovarian stimulation overrides the body's natural selection mechanism, allowing many follicles to grow simultaneously.
However, the approach is not simply "more is better." Too little stimulation may yield too few eggs, while too much can lead to ovarian hyperstimulation syndrome (OHSS). Your doctor's job is to find the balance, the protocol and dosage that is right for your body.
The Science of Follicle Development
To understand ovarian stimulation, it helps to know what is happening inside the ovary.
Follicles and Eggs
An ovarian follicle is a small, fluid-filled sac within the ovary that contains a developing egg (oocyte). At birth, the ovaries contain all the eggs a person will ever have, approximately one to two million. By puberty, this number has declined to about 300,000 to 400,000, and only about 400 to 500 eggs will be ovulated over a reproductive lifetime.
Each month, a cohort of dormant follicles is recruited and begins growing. In a natural cycle, rising FSH (follicle-stimulating hormone) levels at the start of the cycle stimulate these follicles, but as one follicle outpaces the others and begins producing more estradiol, the pituitary reduces FSH output, causing the smaller follicles to stop growing. This is called "selection."
How Stimulation Changes the Process
During IVF stimulation, injectable gonadotropins provide a sustained, elevated level of FSH (and sometimes LH) that maintains the growth of the entire recruited cohort rather than allowing a single dominant follicle to take over. All the follicles that were recruited at the start of the cycle continue to grow, potentially producing 8 to 20 or more mature eggs.
It is a common misconception that IVF stimulation "uses up" eggs that would otherwise be saved for the future. In reality, the eggs in the cohort that would not have been selected during a natural cycle would have simply been reabsorbed by the body. Stimulation rescues these eggs that would otherwise have been lost.
Assessing Your Ovarian Reserve
Before stimulation begins, your doctor evaluates your ovarian reserve, an estimate of the number and quality of remaining eggs, to design the best protocol for you.
Anti-Mullerian Hormone (AMH)
AMH is produced by the small follicles in the ovaries and is one of the most reliable markers of egg supply. It can be measured at any point in the menstrual cycle with a simple blood test.
- High AMH (greater than 3.0 ng/mL): Suggests robust ovarian reserve, and the patient is likely to produce many eggs with stimulation. Very high levels may indicate PCOS and increased OHSS risk.
- Normal AMH (1.0 to 3.0 ng/mL): Indicates typical ovarian reserve for reproductive-age women.
- Low AMH (0.5 to 1.0 ng/mL): Suggests diminished ovarian reserve. The patient may produce fewer eggs per cycle, and the protocol may need to be more aggressive.
- Very low AMH (less than 0.5 ng/mL): Indicates very low reserve. Cycles may yield few eggs, and the treatment plan may include modified approaches.
Antral Follicle Count (AFC)
The AFC is determined by transvaginal ultrasound, typically performed on days 2 to 5 of the menstrual cycle. The doctor counts the small follicles (2 to 10 mm) visible on both ovaries. These antral follicles represent the pool of eggs available for that cycle.
- Normal AFC: 10 to 20 follicles across both ovaries
- High AFC (greater than 20): May indicate PCOS and a strong response to stimulation
- Low AFC (fewer than 6 to 8): Suggests diminished reserve and a potentially modest response
The Stimulation Medications
Gonadotropins: The Primary Stimulants
Gonadotropins are injectable hormones that directly stimulate follicle growth. They come in two primary forms:
FSH-only medications:
- Gonal-F (follitropin alfa)
- Follistim (follitropin beta)
These provide pure FSH and are the most commonly used stimulation drugs. They are available as convenient pre-filled pens with dial-up dosing.
FSH + LH combination:
- Menopur (menotropins): Contains both FSH and LH, derived from purified human sources. Some protocols add LH activity because a small amount of LH is thought to support follicle development and egg maturation, particularly in older patients or those with low LH levels.
Dosing typically ranges from 150 to 450 IU per day, though some patients require lower or higher doses. Your doctor sets the starting dose based on your age, weight, AMH, AFC, and any previous cycle history, then adjusts it during monitoring.
Ovulation Suppression Medications
While gonadotropins stimulate the follicles, your doctor simultaneously prevents premature ovulation using one of two approaches:
GnRH antagonists (Cetrotide or Ganirelix): These are started mid-stimulation, usually around day 5 or 6, or when follicles reach approximately 13 to 14 mm. They block the GnRH receptor in the pituitary, preventing an LH surge. The antagonist protocol is shorter and has become the most widely used approach.
GnRH agonists (Lupron): Started before stimulation begins, these initially stimulate and then suppress the pituitary gland, preventing any LH surge during treatment. The long agonist protocol requires more lead time but provides very reliable suppression.
The Trigger Shot
When follicles reach the target size, the trigger shot is administered to induce the final maturation of the eggs. The two main options are:
- hCG trigger (Ovidrel, Pregnyl, or Novarel): Mimics the natural LH surge. Used in most standard protocols.
- GnRH agonist trigger (Lupron): Used in antagonist protocols, especially when OHSS risk is high. It causes a shorter, more controlled LH surge, reducing OHSS risk.
- Dual trigger: A combination of both hCG and GnRH agonist, sometimes used to optimize egg maturity.
What Happens During Monitoring
Monitoring during stimulation is frequent and involves both blood work and ultrasound. A typical monitoring schedule includes:
Day 1 to 3: Baseline
Before starting stimulation, baseline blood work (FSH, estradiol, LH, sometimes progesterone) and an ultrasound are performed to confirm:
- No large cysts from the previous cycle
- Hormone levels are at an appropriate starting point
- The number of antral follicles available
Day 4 to 6: First Follow-Up
After 3 to 5 days of stimulation, your first monitoring appointment assesses the initial response:
- Estradiol: Should be beginning to rise, indicating follicles are responding
- Ultrasound: Follicles should be starting to grow, though they may still be small (8 to 12 mm)
Based on these results, your doctor may increase, decrease, or maintain your medication dosage.
Day 7 to 10: Mid-Stimulation
Monitoring becomes more frequent, often every 1 to 2 days:
- Estradiol: Should be rising steadily. Each maturing follicle contributes approximately 150 to 300 pg/mL.
- LH: Monitored to ensure no premature surge is occurring
- Ultrasound: Follicles are now growing approximately 1 to 2 mm per day and should be approaching 13 to 17 mm
This is typically when the GnRH antagonist is added (if using an antagonist protocol).
Day 10 to 14: Near Trigger
Monitoring may become daily as your doctor determines the optimal trigger timing:
- Lead follicles should be 17 to 22 mm
- Estradiol should be consistent with the number of mature follicles
- LH and progesterone are checked to confirm no premature ovulation or endometrial transformation
When the criteria are met, your doctor calls with trigger instructions.
How Follicle Growth Translates to Eggs
It is important to understand that not every follicle will yield a mature egg:
- Not every visible follicle contains an egg: Some follicles may be empty
- Not every egg is mature: Eggs from smaller follicles (under about 14 mm at trigger) may be immature and unable to be fertilized
- The target size for mature eggs: Follicles of 17 to 22 mm at the time of trigger are most likely to contain mature eggs
- Typical yield: If you have 15 follicles of appropriate size, you might retrieve 12 to 15 eggs, of which 10 to 12 might be mature
Potential Side Effects of Ovarian Stimulation
The medications and the ovarian response they produce can cause a range of side effects:
Common and Expected
- Bloating and abdominal fullness: As the ovaries enlarge with multiple growing follicles, you may feel bloated and uncomfortable, particularly in the later days of stimulation
- Mild pelvic discomfort or heaviness: The enlarged ovaries can cause a sensation of pressure
- Mood changes: Hormonal fluctuations can affect your emotions. Feeling more tearful, irritable, or anxious than usual is common
- Fatigue: The combination of hormonal changes, medication side effects, and the stress of treatment can leave you feeling tired
- Injection site reactions: Mild redness, bruising, or tenderness at the injection sites
- Headaches: Occasionally reported, especially in the first few days of stimulation
Less Common but Important
- Ovarian hyperstimulation syndrome (OHSS): Occurs in approximately 3% or fewer of IVF cycles. The ovaries become swollen and leak fluid into the abdomen. Mild cases involve bloating and discomfort; severe cases can cause rapid weight gain, difficulty breathing, and reduced urine output, requiring medical attention. Risk factors include young age, low BMI, PCOS, high AMH, and a large number of follicles.
What You Can Do
- Stay hydrated: Drink plenty of water throughout stimulation
- Eat protein-rich foods: Some evidence suggests high-protein diets may help reduce bloating
- Wear comfortable clothing: Your abdomen may be distended, especially in the final days
- Avoid strenuous exercise: As the ovaries enlarge, vigorous activity increases the risk of ovarian torsion (twisting), a rare but serious complication. Walking and gentle movement are fine.
- Rest when needed: Listen to your body and take it easy when you feel fatigued
A Note on Medical Guidance
This article is for informational purposes only and is not a substitute for professional medical advice. The authors of this blog are not doctors or medical professionals. Always consult with your fertility specialist or healthcare provider before making any decisions about your treatment. Every person's fertility journey is unique, and your doctor can provide guidance tailored to your specific situation.
Conclusion
Ovarian stimulation is a remarkable medical intervention that allows the body to produce multiple eggs in a single cycle, dramatically improving the chances of creating viable embryos. While the daily injections and frequent monitoring can feel demanding, understanding the purpose behind each step can make the experience less daunting. Your doctor is carefully calibrating every aspect of your stimulation to give you the best possible outcome while keeping you safe. Trust the process, communicate openly with your medical team, and take each day one injection at a time.
